HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study.

AbstractBACKGROUND:
The postadolescent form of acne papulopustulosa, also referred to as 'acne tarda' can have substantial negative impact on Quality of Life, especially in adult female patients.
OBJECTIVE:
Although the Dermatology Life Quality Index (DLQI) is widely used, empirical evidence about its performance in adult female acne patients is lacking.
METHODS:
In this prospective cohort study, we have investigated the sensitivity to change of the DLQI in 53 female adult acne patients with mild to moderate facial acne treated with azelaic acid (AzA) 15% gel twice daily over 24 weeks.
RESULTS:
Mean Investigator Static Global Assessment (ISGA) score was 2.3 (SD 0.5) at baseline and ranged from 0.9 (SD 0.3) to 2.1 (SD 0.4) at the end of the study in the 'Highly Improved' and 'Unchanged' responder groups respectively. The mean baseline DLQI score was 5.1 (SD 4.2). The Effect Size in the responder group 'Highly Improved' was 0.66; in group 'Improved' 0.62 and 0.23 in group 'Unchanged'. At the end of study, the mean DLQI score ranged from 1.1 (SD 1.5) in the 'Highly Improved' group to 3.7 (SD 6.0) in the 'Unchanged' group.
CONCLUSION:
The results support the sensitivity to change of the DLQI in this population.
AuthorsC Richter, C Trojahn, K Hillmann, G Dobos, V Kanti, A Vogt, U Blume-Peytavi, J Kottner
JournalJournal of the European Academy of Dermatology and Venereology : JEADV (J Eur Acad Dermatol Venereol) Vol. 31 Issue 1 Pg. 169-174 (Jan 2017) ISSN: 1468-3083 [Electronic] England
PMID27393576 (Publication Type: Journal Article, Validation Study)
Copyright© 2016 European Academy of Dermatology and Venereology.
Topics
  • Acne Vulgaris (physiopathology)
  • Face (pathology)
  • Female
  • Humans
  • Quality of Life

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: